Tags

Type your tag names separated by a space and hit enter

Identification of molecular descriptors for design of novel Isoalloxazine derivatives as potential Acetylcholinesterase inhibitors against Alzheimer's disease.
J Biomol Struct Dyn. 2017 Jun; 35(8):1729-1742.JB

Abstract

In Alzheimer's disease (AD), the level of Acetylcholine (ACh) neurotransmitter is reduced. Since Acetylcholinesterase (AChE) cleaves ACh, inhibitors of AChE are very much sought after for AD treatment. The side effects of current inhibitors necessitate development of newer AChE inhibitors. Isoalloxazine derivatives have proved to be promising (AChE) inhibitors. However, their structure-activity relationship studies have not been reported till date. In the present work, various quantitative structure-activity relationship (QSAR) building methods such as multiple linear regression (MLR), partial least squares ,and principal component regression were employed to derive 3D-QSAR models using steric and electrostatic field descriptors. Statistically significant model was obtained using MLR coupled with stepwise selection method having r2 = .9405, cross validated r2 (q2) = .6683, and a high predictability (pred_r2 = .6206 and standard error, pred_r2se = .2491). Steric and electrostatic contribution plot revealed three electrostatic fields E_496, E_386 and E_577 and one steric field S_60 contributing towards biological activity. A ligand-based 3D-pharmacophore model was generated consisting of eight pharmacophore features. Isoalloxazine derivatives were docked against human AChE, which revealed critical residues implicated in hydrogen bonds as well as hydrophobic interactions. The binding modes of docked complexes (AChE_IA1 and AChE_IA14) were validated by molecular dynamics simulation which showed their stable trajectories in terms of root mean square deviation and molecular mechanics/Poisson-Boltzmann surface area binding free energy analysis revealed key residues contributing significantly to overall binding energy. The present study may be useful in the design of more potent Isoalloxazine derivatives as AChE inhibitors.

Authors+Show Affiliations

a Computational Biology Laboratory, Department of Biotechnology and Bioinformatics , North-Eastern Hill University , Shillong 793022 , India.b Molecular Biology Laboratory, Department of Biotechnology and Bioinformatics , North-Eastern Hill University , Shillong 793022 , India.c Center for Advanced Studies in Chemistry , North-Eastern Hill University , Shillong 793022 , India.a Computational Biology Laboratory, Department of Biotechnology and Bioinformatics , North-Eastern Hill University , Shillong 793022 , India.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

27410776

Citation

Gurung, Arun Bahadur, et al. "Identification of Molecular Descriptors for Design of Novel Isoalloxazine Derivatives as Potential Acetylcholinesterase Inhibitors Against Alzheimer's Disease." Journal of Biomolecular Structure & Dynamics, vol. 35, no. 8, 2017, pp. 1729-1742.
Gurung AB, Aguan K, Mitra S, et al. Identification of molecular descriptors for design of novel Isoalloxazine derivatives as potential Acetylcholinesterase inhibitors against Alzheimer's disease. J Biomol Struct Dyn. 2017;35(8):1729-1742.
Gurung, A. B., Aguan, K., Mitra, S., & Bhattacharjee, A. (2017). Identification of molecular descriptors for design of novel Isoalloxazine derivatives as potential Acetylcholinesterase inhibitors against Alzheimer's disease. Journal of Biomolecular Structure & Dynamics, 35(8), 1729-1742. https://doi.org/10.1080/07391102.2016.1192485
Gurung AB, et al. Identification of Molecular Descriptors for Design of Novel Isoalloxazine Derivatives as Potential Acetylcholinesterase Inhibitors Against Alzheimer's Disease. J Biomol Struct Dyn. 2017;35(8):1729-1742. PubMed PMID: 27410776.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Identification of molecular descriptors for design of novel Isoalloxazine derivatives as potential Acetylcholinesterase inhibitors against Alzheimer's disease. AU - Gurung,Arun Bahadur, AU - Aguan,Kripamoy, AU - Mitra,Sivaprasad, AU - Bhattacharjee,Atanu, Y1 - 2016/07/28/ PY - 2016/7/14/pubmed PY - 2018/2/24/medline PY - 2016/7/14/entrez KW - 3D-QSAR KW - Acetylcholinesterase (AChE) KW - Isoalloxazine KW - molecular docking, molecular dynamics simulation and MM/PBSA KW - pharmacophore SP - 1729 EP - 1742 JF - Journal of biomolecular structure & dynamics JO - J Biomol Struct Dyn VL - 35 IS - 8 N2 - In Alzheimer's disease (AD), the level of Acetylcholine (ACh) neurotransmitter is reduced. Since Acetylcholinesterase (AChE) cleaves ACh, inhibitors of AChE are very much sought after for AD treatment. The side effects of current inhibitors necessitate development of newer AChE inhibitors. Isoalloxazine derivatives have proved to be promising (AChE) inhibitors. However, their structure-activity relationship studies have not been reported till date. In the present work, various quantitative structure-activity relationship (QSAR) building methods such as multiple linear regression (MLR), partial least squares ,and principal component regression were employed to derive 3D-QSAR models using steric and electrostatic field descriptors. Statistically significant model was obtained using MLR coupled with stepwise selection method having r2 = .9405, cross validated r2 (q2) = .6683, and a high predictability (pred_r2 = .6206 and standard error, pred_r2se = .2491). Steric and electrostatic contribution plot revealed three electrostatic fields E_496, E_386 and E_577 and one steric field S_60 contributing towards biological activity. A ligand-based 3D-pharmacophore model was generated consisting of eight pharmacophore features. Isoalloxazine derivatives were docked against human AChE, which revealed critical residues implicated in hydrogen bonds as well as hydrophobic interactions. The binding modes of docked complexes (AChE_IA1 and AChE_IA14) were validated by molecular dynamics simulation which showed their stable trajectories in terms of root mean square deviation and molecular mechanics/Poisson-Boltzmann surface area binding free energy analysis revealed key residues contributing significantly to overall binding energy. The present study may be useful in the design of more potent Isoalloxazine derivatives as AChE inhibitors. SN - 1538-0254 UR - https://www.unboundmedicine.com/medline/citation/27410776/Identification_of_molecular_descriptors_for_design_of_novel_Isoalloxazine_derivatives_as_potential_Acetylcholinesterase_inhibitors_against_Alzheimer's_disease_ DB - PRIME DP - Unbound Medicine ER -